Memorial Sloan Kettering Cancer Center
Clinical trials sponsored by Memorial Sloan Kettering Cancer Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New imaging agent could help spot hidden tumors Results expected Sep 2026 (estimated)
- Brain tumor imaging study aims to pinpoint recurrence hotspots Results expected Sep 2026 (estimated)
- New combo aims to shrink pancreatic tumors before surgery Results expected Sep 2026 (estimated)
- CAR-T Therapy's hidden toll on the brain: new study investigates Results expected Sep 2026 (estimated)
- Could a Two-Week radiation blast be enough for early breast cancer? Results expected Sep 2026 (estimated)
-
New drug switch may control lung cancer longer in High-Risk patients
Disease control Stopped earlyThis study looked at whether switching from the immunotherapy durvalumab to the targeted drug sotorasib can better control locally advanced non-small cell lung cancer in patients with a KRAS G12C mutation and signs of remaining cancer (minimal residual disease). Ten participants …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat prostate cancer
Disease control Stopped earlyThis study looked at a combination of two drugs, talazoparib and temozolomide, in 16 men with advanced prostate cancer that had spread and stopped responding to hormone therapy. The goal was to find the safest dose and see if the drugs could shrink tumors. The study was completed…
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Experimental drug tested for rare cancer, trial stopped early
Disease control Stopped earlyThis study tested a drug called XmAb23104 in people with advanced sarcoma, a rare cancer. The goal was to see if the drug could shrink tumors and if it was safe. Only 6 people took part before the study was ended early.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC